glp 1 2025 GLP-1 Receptor Agonist Market Growth Analysis GLP-1 Shortage = Over -

Higher Dosage Approval: The FDA approved a new, higher 7.2 mg dose of Wegovy (Wegovy HD), designed to achieve greater, long-term weight reduction.Safety Concerns & Regulations: Reports have linked Wegovy to a potential risk of "eye stroke" (ischemic optic neuropathy)

Resistance training that preserves muscle during weight loss continues supporting metabolic rate and body composition during maintenance

Visualize Your Semaglutide Clearance Use the free GLP3Planner calculator to model how semaglutide levels decay after your last dose, then map your tirzepatide titration schedule from 2.5mg to your target dose

Less common: Gallbladder disease, pancreatitis

BMI Requirement Adults with BMI 30 (obesity) or BMI 25 (overweight) with at least one weight-related condition